Share

April 09, 2019; 92 (15 Supplement) May 7, 2019

Reduced risk of progressive multifocal leukoencephalopathy (PML) associated with natalizumab extended interval dosing (EID): updated analysis of the TOUCH® Prescribing Program database (S26.006)

Lana Zhovtis Ryerson, John Foley, Ih Chang, Ilya Kister, Gary Cutter, Ryan Metzger, Judith Goldberg, Xiaochun Li, Evan Riddle, Karen Smirnakis, Rachna Kasliwal, Zheng Ren, Christophe Hotermans, Pei-Ran Ho, Nolan Campbell
First published April 16, 2019,
Citation
Permissions

Make Comment

See Comments

Downloads
0

Share

Article Information

vol. 92 no. 15 Supplement S26.006
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • First Published April 16, 2019.
Copyright & Usage: 
© 2019

Author Disclosures

    1. Lana Zhovtis Ryerson1,
    2. John Foley2,
    3. Ih Chang3,
    4. Ilya Kister1,
    5. Gary Cutter4,
    6. Ryan Metzger2,
    7. Judith Goldberg5,
    8. Xiaochun Li5,
    9. Evan Riddle3,
    10. Karen Smirnakis3,
    11. Rachna Kasliwal3,
    12. Zheng Ren3,
    13. Christophe Hotermans3,
    14. Pei-Ran Ho3 and
    15. Nolan Campbell3
  1. Lana Zhovtis Ryerson1,
  2. John Foley2,
  3. Ih Chang3,
  4. Ilya Kister1,
  5. Gary Cutter4,
  6. Ryan Metzger2,
  7. Judith Goldberg5,
  8. Xiaochun Li5,
  9. Evan Riddle3,
  10. Karen Smirnakis3,
  11. Rachna Kasliwal3,
  12. Zheng Ren3,
  13. Christophe Hotermans3,
  14. Pei-Ran Ho3 and
  15. Nolan Campbell3
  1. 1Department of Neurology, NYU Langone Health, New York University New York NY United States
  2. 2Rocky Mountain MS Clinic Salt Lake City UT United States
  3. 3Biogen Cambridge MA United States
  4. 4University of Alabama School of Public Health Birmingham AL United States
  5. 5New York University School of Medicine New York NY United States

Article usage

Article usage: April 2019 to January 2021

AbstractFullPdfSource
Apr 2019700Highwire
May 20192700Highwire
Jun 20192500Highwire
Jul 20191900Highwire
Aug 20193700Highwire
Sep 20194200Highwire
Oct 20192800Highwire
Nov 20191900Highwire
Dec 20192600Highwire
Jan 20202100Highwire
Feb 20201400Highwire
Mar 2020500Highwire
Apr 2020800Highwire
May 2020500Highwire
Jun 20201200Highwire
Jul 20201000Highwire
Aug 2020500Highwire
Sep 2020800Highwire
Oct 2020500Highwire
Nov 2020600Highwire
Dec 20202000Highwire
Jan 2021700Highwire

Disputes & Debates: Rapid online correspondence

No comments have been published for this article.
Comment

NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.

  • Stay timely. Submit only on articles published within the last 8 weeks.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • 200 words maximum.
  • 5 references maximum. Reference 1 must be the article on which you are commenting.
  • 5 authors maximum. Exception: replies can include all original authors of the article.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Disputes & Debates Submission Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Alert Me